2 completed, 1 enrolling by invitation, 1 recruiting, 1 unknown. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Enrolling by invitation 1, Recruiting 1, Unknown 1 |
Follow Neuroinflammation: new trials by email Literature Review of Neuroinflammation trials Research Report on Neuroinflammation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT) Vitamin D3 (Cholecalciferol) - Traumatic Brain Injury (TBI) Patients, Neuroinflammation | Phase 2 | Recruiting | Lagos State University | 240 | 2026-03-02 | 2026-05-13 |
| Effectiveness of Ashwagandha in Schizophrenia Patients on Risperidone Risperidone 4mg/day, Ashwagandha, Placebo - Schizophrenia Patients, Neuroinflammation | Phase 2 | Completed | Hasanuddin University | 80 | 2025-10-01 | 2026-05-12 |
| Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent RVP-001 - Central Nervous System (CNS) Lesions, Brain Metastases | Phase 2 | Completed | Reveal Pharmaceuticals Inc. | 18 | 2024-08-15 | 2025-12-26 |
| Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 IV normal saline, IV immunoglobulin - Systemic Inflammation, Neuroinflammation | Phase 2 | Enrolling by invitation | National Institute of Neurological Disorders and Stroke (NINDS) | 45 | 2023-07-10 | 2026-11-10 |
| The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment PMPBB3, THK5351 - Post-stroke Cognitive Impairment, Neuroinflammation | Phase 2 | Unknown | Chang Gung Memorial Hospital | 80 | 2020-11-01 | 2023-05-01 |
Neuroinflammatory Diseases (5) · Brain Injuries, Traumatic (1) · Brain Neoplasms (1) · COVID-19 (1) · Central Nervous System Neoplasms (1) · Frontotemporal Dementia (1) · Glioma (1) · Inflammation (1) · Meningioma (1) · Multiple Sclerosis (1) · Neoplasms (1) · Neurilemmoma (1) · Neurofibroma (1) · Neuroma, Acoustic (1) · Post-Acute COVID-19 Syndrome (1)
Nervous System Diseases (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Inflammation (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Mental Disorders (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Injuries (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Cranial Nerve Diseases (1) · Cranial Nerve Neoplasms (1)
Ashwagandha (1) · Cholecalciferol (1) · Immunoglobulins, Intravenous (1) · Mn-PyC3A (1) · Risperidone (1) · Saline Solution (1) · THK5351 (1)
Chang Gung Memorial Hospital (1) · Hasanuddin University (1) · Lagos State University (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Reveal Pharmaceuticals Inc. (1)
United States (2) · Indonesia (1) · Nigeria (1) · Taiwan (1)
Avindra Nath, M.D. (1) · Masnaeni Awaliah, MD (1)
R44CA261240 (1)